Are MDCK Cells Transfected with the Human MDR1 Gene a Good Model of the Human Intestinal Mucosa?
暂无分享,去创建一个
[1] F. Sharom,et al. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. , 1995, The Biochemical journal.
[2] F. Sharom,et al. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. , 1999, Biochemistry.
[3] L. Reuss,et al. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[4] I. Schoots,et al. Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. , 2001, Molecular pharmacology.
[5] P. Borst,et al. Multidrug resistance and the role of P-glycoprotein knockout mice. , 1995, European journal of cancer.
[6] C. Higgins,et al. The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface. , 1997, Biochimica et biophysica acta.
[7] G. Meer,et al. Two strains of the Madin‐Darby canine kidney (MDCK) cell line have distinct glycosphingolipid compositions. , 1986, The EMBO journal.
[8] J. Seelig,et al. Partitioning of local anesthetics into membranes: surface charge effects monitored by the phospholipid head-group. , 1988, Biochimica et biophysica acta.
[9] L. Benet,et al. Active secretion and enterocytic drug metabolism barriers to drug absorption. , 2001, Advanced drug delivery reviews.
[10] B. Rothen‐Rutishauser,et al. P-Glycoprotein in cell cultures: a combined approach to study expression, localisation, and functionality in the confocal microscope. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] J. Riordan,et al. Multidrug-resistance phenotype in Chinese hamster ovary cells. , 1983, Cancer treatment reports.
[12] A. Read. Genes IV , 1990 .
[13] M. Ichise,et al. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line , 2000, European Journal of Nuclear Medicine.
[14] R. Conradi,et al. Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. , 1993, Biochemical and biophysical research communications.
[15] J. Tolan,et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.
[16] J. R. Sportsman,et al. Association of intestinal peptide transport with a protein related to the cadherin superfamily. , 1994, Science.
[17] R. Evers,et al. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. , 1996, The Journal of clinical investigation.
[18] Y. Sawada,et al. Transport of digoxin into brain microvessels and choroid plexuses isolated from guinea pig. , 1988, Journal of pharmaceutical sciences.
[19] I. Pastan,et al. Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. , 1990, The Journal of biological chemistry.
[20] J. H. Beijnen,et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.
[21] H. Melhus,et al. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. , 2001, The Journal of pharmacology and experimental therapeutics.
[22] T. Cantz,et al. Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF‐B , 1998, Hepatology.
[23] R. Borchardt. The application of cell culture systems in drug discovery and development. , 1995, Journal of drug targeting.
[24] J Ferté,et al. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. , 2000, European journal of biochemistry.
[25] P Langguth,et al. P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. , 1998, Journal of pharmaceutical sciences.
[26] R. Borchardt,et al. A Functional Assay for Quantitation of the Apparent Affinities of Ligands of P-Glycoprotein in Caco-2 Cells , 2001, Pharmaceutical Research.
[27] I. Pastan,et al. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. , 1994, Molecular pharmacology.
[28] D. Keppler,et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. , 1999, Biochimica et biophysica acta.
[29] K. Bock,et al. Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells. , 2000, Biochemical pharmacology.
[30] M Rowland,et al. Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[31] V. Ling,et al. P-glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer. , 1997, European journal of biochemistry.
[32] P. Borst,et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[33] Thomas J. Vidmar,et al. The Madin Darby Canine Kidney (MDCK) Epithelial Cell Monolayer as a Model Cellular Transport Barrier , 2004, Pharmaceutical Research.
[34] T. Walle,et al. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. , 1999, Biochemical pharmacology.
[35] Y. Sugiyama,et al. Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[36] R. Borchardt,et al. Characterization of the Efflux Transporter(s) Responsible for Restricting Intestinal Mucosa Permeation of the Coumarinic Acid-Based Cyclic Prodrug of the Opioid Peptide DADLE , 2002, Pharmaceutical Research.
[37] Per Artursson,et al. Intestinal Drug Absorption and Metabolism in Cell Cultures: Caco-2 and Beyond , 1997, Pharmaceutical Research.
[38] A. Waseem Malick,et al. The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development , 1996 .
[39] A. Smith,et al. Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum. , 1998, Journal of the National Cancer Institute.
[40] B. Sikic,et al. MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells , 2000, British Journal of Cancer.
[41] W. Lamers,et al. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport , 1985, Hepatology.
[42] T. Litman,et al. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. , 1999, Cancer letters.
[43] K. Brouwer,et al. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[44] C. Vergely,et al. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. , 1993, Cancer research.
[45] K. Luthman,et al. Caco-2 monolayers in experimental and theoretical predictions of drug transport. , 2001, Advanced drug delivery reviews.
[46] G. van Meer,et al. Sorting of newly synthesized galactosphingolipids to the two surface domains of epithelial cells , 1996, The Journal of cell biology.
[47] James E. Polli,et al. Influence of Passive Permeability on Apparent P-glycoprotein Kinetics , 2000, Pharmaceutical Research.
[48] A. Giuliano,et al. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. , 1999, Cancer research.
[49] M. Kool,et al. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. , 1998, The Journal of clinical investigation.
[50] M. Takano,et al. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene. , 1997, Biochemical pharmacology.
[51] U. Christians,et al. Active transport of the angiotensin‐II antagonist losartan and its main metabolite EXP 3174 across MDCK‐MDR1 and Caco‐2 cell monolayers , 2000, British journal of pharmacology.
[52] T. Tsuruo,et al. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. , 1993, The Journal of biological chemistry.
[53] V. H. Lee,et al. Age-dependent Expression of P-Glycoprotein gp17O in Caco-2 Cell Monolayers , 1996, Pharmaceutical Research.
[54] M. Kool,et al. The multidrug resistance protein family. , 1999, Biochimica et biophysica acta.
[55] F. Sharom,et al. Interaction of P-glycoprotein with defined phospholipid bilayers: a differential scanning calorimetric study. , 1997, Biochemistry.
[56] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[57] D. Keppler,et al. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. , 1997, The Biochemical journal.
[58] R. Evers,et al. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1 , 1997, FEBS letters.
[59] Y Zhang,et al. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.